Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
about
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies.Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs).IgG Glyco-Engineering to Improve IVIg Potency
P2860
Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enhanced Effector Functions Du ...... tor Cell Fcγ Receptor Profile.
@en
type
label
Enhanced Effector Functions Du ...... tor Cell Fcγ Receptor Profile.
@en
prefLabel
Enhanced Effector Functions Du ...... tor Cell Fcγ Receptor Profile.
@en
P2093
P2860
P50
P356
P1476
Enhanced Effector Functions Du ...... ctor Cell Fcγ Receptor Profile
@en
P2093
Arthur E H Bentlage
Carolien A M Koeleman
Christine W Bruggeman
Louise W Treffers
Sietse Q Nagelkerke
Suzanne Lissenberg-Thunnissen
Theo Rispens
Timo K van den Berg
P2860
P304
P356
10.4049/JIMMUNOL.1700116
P407
P577
2017-05-31T00:00:00Z